Concepedia

Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study

Michael Trauner, Frederik Nevens, Mitchell L. Shiffman, Joost P.H. Drenth, Christopher L. Bowlus, Vı́ctor Vargas, Pietro Andreoné, Gideon M. Hirschfield, Richard Pencek, Elizabeth Smoot Malecha,

˜The œLancet. Gastroenterology & hepatology · 2019 · 176 citations · 21 references

DOIFull text

Open access

Concepts

References

21

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

Brent A. Neuschwander‐Tetri, Rohit Loomba, Arun J. Sanyal et al. · The Lancet · 2014 · 2.2K citations

, , +14

EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis

Gideon M. Hirschfield, Ulrich Beuers, Christophe Corpechot et al. · Journal of Hepatology · 2017 · 1.5K citations · Full text

, , +13

Primary Biliary Cirrhosis

2011 · 1.2K citations

A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

Frederik Nevens, Pietro Andreoné, G. Mazzella et al. · New England Journal of Medicine · 2016 · 1.1K citations · Full text

, , +16

Primary biliary cirrhosis # †

Keith D. Lindor, Eric M. Gershwin, Raoul Poupon et al. · Hepatology · 2009 · 1.1K citations

, , +11